Microdermis launches Provodine in award-winning packaging

Ampac’s seven-layer laminate provides package integrity, barrier, portability, and dispensing functionality for this next-generation infection control product.

Next-generation infection control product Provodine cream includes aggressive chemical compounds that were addressed by an award-winning seven-layer flexible packaging structure for the product’s 3-mL packette shown here.
Next-generation infection control product Provodine cream includes aggressive chemical compounds that were addressed by an award-winning seven-layer flexible packaging structure for the product’s 3-mL packette shown here.

A laminated flexible film structure from Ampac proved essential in helping lifesciences company Microdermis Corp. launch its flagship product Provodine®, an infection-control product to be initially targeted to the U.S. military.

The proprietary structure earned a 2015 AmeriStar Award in the Drug & Pharmaceutical category.

Princeton, NJ-based Microdermis Corp. is a lifesciences company that focuses on the development of novel products based on its patented Amidermal® technology.

Harry Corless, VP of Technical Operations for Microdermis, notes, “Provodine is a cream targeted initially only in the U.S., but soon globally starting in South America. Beginning with the U.S. military, it will be sold into the professional market, to hospitals, clinics, and long-term care facilities.”

Provodine is sold presently in 3-mL packettes/sachets, 4-oz bottles, and 16-oz bottles with pumps, with additional SKUs planned for next year. For this article, the focus is on the product’s fast-growing packettes.

Microdermis refers to the product as a next-generation professional antiseptic that meets or exceeds FDA requirements for use as a surgical scrub, pre-operative skin preparation, healthcare personnel hand wash, and first aid antiseptic.

Provodine uses Microdermis’ Amidermal technology for enhanced kill strength of dangerous microbes. Provodine has been tested against most category 1 (deadly/weaponized/no known cures) pathogens and kills them all within 30 seconds of exposure time, even after 12 hours of dry time on exposed skin.

There are currently no known resistant strains to Provodine, useful for deployment in challenging environments with an unknown mix of infection sources, such as in military field hospitals, and with globally deployed NGO (non-governmental organization) personnel.

Provodine uses Povidone-Iodine and contains a proprietary blend of skin moisturizers and humectants that nourish and rebuild the skin, eliminating dryness and cracking, which are not only uncomfortable, but also create portals for microbes.

Corless says, “Provodine has a broad spectrum of kill, provides increased longevity of protection, and is more gentle to the skin than other competitive products in the market today.”

Considerable packaging requirements

Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
GET YOUR COPY
Fresh from the show floor: pharma packaging innovations for 2026
Recyclable pill bottles are gaining pharmacy ground
Aluminum and paper-based prescription bottles are moving from concept to commercial reality. Here's what pharmacy and packaging leaders need to know.
Read More
Recyclable pill bottles are gaining pharmacy ground